Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases
Frank J. Dekker, Thea van den Bosch, Nathaniel I. Martin
Drug Discovery Today (2013) Vol. 19, Iss. 5, pp. 654-660
Open Access | Times Cited: 130

Showing 1-25 of 130 citing articles:

Mechanisms of NF-κB p65 and strategies for therapeutic manipulation
Sivagami Giridharan, Mythily Srinivasan
Journal of Inflammation Research (2018) Vol. Volume 11, pp. 407-419
Open Access | Times Cited: 506
Epigenetic mechanisms of chronic pain
Giannina Descalzi, Daigo Ikegami, Toshikazu Ushijima, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 4, pp. 237-246
Open Access | Times Cited: 343
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Amy K. Rines, Kfir Sharabi, Clint D.J. Tavares, et al.
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 11, pp. 786-804
Open Access | Times Cited: 317
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
Wiktor Szymański, Maria E. Ourailidou, Willem A. Velema, et al.
Chemistry - A European Journal (2015) Vol. 21, Iss. 46, pp. 16517-16524
Open Access | Times Cited: 129
Anti-aging pharmacology: Promises and pitfalls
Alexander Vaiserman, Oleh Lushchak, Alexander Koliada
Ageing Research Reviews (2016) Vol. 31, pp. 9-35
Closed Access | Times Cited: 129
Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation
Niek G.J. Leus, Martijn R. H. Zwinderman, Frank J. Dekker
Current Opinion in Chemical Biology (2016) Vol. 33, pp. 160-168
Open Access | Times Cited: 124
HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity
Niek G.J. Leus, Petra E. van der Wouden, Thea van den Bosch, et al.
Biochemical Pharmacology (2016) Vol. 108, pp. 58-74
Open Access | Times Cited: 113
Role of SIRT1 in Modulating Acetylation of the Sarco-Endoplasmic Reticulum Ca 2+ -ATPase in Heart Failure
Przemek A. Gorski, Seung Pil Jang, Dongtak Jeong, et al.
Circulation Research (2019) Vol. 124, Iss. 9
Open Access | Times Cited: 107
Bromodomain Histone Readers and Cancer
Abhinav K. Jain, Michelle Barton
Journal of Molecular Biology (2016) Vol. 429, Iss. 13, pp. 2003-2010
Closed Access | Times Cited: 105
The epigenetic implication in coronavirus infection and therapy
Sandra Atlante, Alessia Mongelli, Veronica Barbi, et al.
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 96
HDAC inhibitors: A new promising drug class in anti-aging research
E. G. Pasyukova, Alexander Vaiserman
Mechanisms of Ageing and Development (2017) Vol. 166, pp. 6-15
Closed Access | Times Cited: 90
Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration
Saima Zafar, Shehzadi Irum Fatima, Matthias Schmitz, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 118-118
Open Access | Times Cited: 12
Histone deacetylases and their inhibitors in inflammatory diseases
Sen-Yu Zhang, Liying Zhang, Ri Wen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117295-117295
Open Access | Times Cited: 12
omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases
Chelsea X. Alvarado, Mary B. Makarious, Cory A. Weller, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 1, pp. 150-164
Open Access | Times Cited: 9
Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy
Leila Haery, Ryan C. Thompson, Thomas D. Gilmore
Genes & Cancer (2015) Vol. 6, Iss. 5-6, pp. 184-213
Open Access | Times Cited: 86
Butyrate protects against disruption of the blood‐milk barrier and moderates inflammatory responses in a model of mastitis induced by lipopolysaccharide
Jingjing Wang, Zhengkai Wei, Xu Zhang, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 21, pp. 3811-3822
Open Access | Times Cited: 80
The Histone Acetyltransferase GCN5 Expression Is Elevated and Regulated by c-Myc and E2F1 Transcription Factors in Human Colon Cancer
Yan-Wei Yin, Hongjian Jin, Wenjing Zhao, et al.
Gene Expression (2015) Vol. 16, Iss. 4, pp. 187-196
Open Access | Times Cited: 73
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases
Roman P. Simon, Dina Robaa, Zayan Alhalabi, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 4, pp. 1249-1270
Closed Access | Times Cited: 70
Drugging the pain epigenome
Ellen Niederberger, Eduard Resch, Michael J. Parnham, et al.
Nature Reviews Neurology (2017) Vol. 13, Iss. 7, pp. 434-447
Closed Access | Times Cited: 69
Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage
Beatriz Suárez-Álvarez, José Luis Morgado‐Pascual, Sandra Rayego‐Mateos, et al.
Journal of the American Society of Nephrology (2016) Vol. 28, Iss. 2, pp. 504-519
Open Access | Times Cited: 68
RORα is crucial for attenuated inflammatory response to maintain intestinal homeostasis
Se Kyu Oh, Dongha Kim, Kyeongkyu Kim, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 42, pp. 21140-21149
Open Access | Times Cited: 63
Baicalein exhibits anti-inflammatory effects via inhibition of NF-κB transactivation
Raghavendra S. Patwardhan, Deepak Sharma, Maikho Thoh, et al.
Biochemical Pharmacology (2016) Vol. 108, pp. 75-89
Closed Access | Times Cited: 62
Management of epigenomic networks entailed in coronavirus infections and COVID-19
Ranim El Baba, Georges Herbein
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Insights into Machine Learning-based Approaches for Virtual Screening in Drug Discovery: Existing Strategies and Streamlining Through FP-CADD
Waqar Hussain, Nouman Rasool, Yaser Daanial Khan
Current Drug Discovery Technologies (2020) Vol. 18, Iss. 4, pp. 463-472
Closed Access | Times Cited: 53
Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
Anna Rugowska, Alicja Starosta, Patryk Konieczny
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top